{"SPADE_UN_15839": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15839", "Peptide Name": 14, "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "GLWGVIKALGGHVG", "Sequence Length": 14, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:A549 (EC50>100 Î¼M)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C64H102N18O15", "Mass": 1363.61, "PI": 8.76, "Net Charge": 2, "Hydrophobicity": 0.88, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "De novo design of anticancer peptides by ensemble artificial neural networks", "Pubmed ID": "30953170", "Reference": "J Mol Model. 2019 Apr 5;25(5)112.", "Author": "Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=30953170"}], "Frequent Amino Acids": "GLV", "Absent Amino Acids": "CDEFMNOPQRSTUY", "Basic Residues": 2, "Acidic Residues": 0, "Hydrophobic Residues": 7, "Polar Residues": 5, "Positive Residues": 2, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_05519", "Similarity": 1.0, "Sequence": "NKGCAICSIGAACLVDGPIPDFEIAGATGLFGLWG"}, {"SPADE_ID": "SPADE_N_06150", "Similarity": 1.0, "Sequence": "MKKAVIVENKGCATCSIGAACLVDGPIPDFEIAGATGLFGLWG"}, {"SPADE_ID": "SPADE_N_06243", "Similarity": 1.0, "Sequence": "NKGCATCSIGAACLVDGPIPDFEIAGATGLFGLWG"}]}}}